Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report

BACKGROUND: Half of U.S. adults have received at least one dose of the COVID-19 vaccines produced by either Pfizer, Moderna, or Johnson and Johnson, which represents a major milestone in the ongoing pandemic. Given the emergency use authorizations for these vaccines, their side effects and safety we...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasnie, Ammar A., Hasnie, Usman A., Patel, Nirav, Aziz, Muhammad U., Xie, Min, Lloyd, Steven G., Prabhu, Sumanth D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334333/
https://www.ncbi.nlm.nih.gov/pubmed/34348657
http://dx.doi.org/10.1186/s12872-021-02183-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334333/
https://www.ncbi.nlm.nih.gov/pubmed/34348657
http://dx.doi.org/10.1186/s12872-021-02183-3

Ejemplares similares